Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asena Gokcay Canpolat

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Pharmacology & Physiology|September 14, 2021
Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca<sup>2+</sup> abnormalities and mitochondrial dysfunctionAysegul Durak, Erman Akkus, Asena Gokcay Canpolat, et al.
Clinical Endocrinology|July 8, 2017
Is primary hyperparathyroidism a cause of endothelial dysfunction?Sevgi Colak, Berna Imge Aydogan, Asena Gokcay Canpolat, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Pharmacology & Physiology|September 14, 2021
Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca<sup>2+</sup> abnormalities and mitochondrial dysfunctionAysegul Durak, Erman Akkus, Asena Gokcay Canpolat, et al.
Clinical Endocrinology|July 8, 2017
Is primary hyperparathyroidism a cause of endothelial dysfunction?Sevgi Colak, Berna Imge Aydogan, Asena Gokcay Canpolat, et al.
Pageof 1